Devises / ANIP
ANIP: ANI Pharmaceuticals Inc
93.50
USD
0.97
(1.05%)
Le taux de change de ANIP a changé de 1.05% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 91.97 et à un maximum de 93.72.
Suivez la dynamique ANI Pharmaceuticals Inc. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ANIP Nouvelles
- J&J Ends Imaavy Development in Rheumatoid Arthritis Post Study Failure
- Ani Pharmaceuticals stock hits 52-week high at 93.0 USD
- Adaptive Biotechnologies Corporation (ADPT) Hits Fresh High: Is There Still Room to Run?
- ANI Pharmaceuticals (ANIP) is a Great Momentum Stock: Should You Buy?
- IOVA Stock Drops 6% on $350M Common Stock Offering
- Is ANI (ANIP) a Solid Growth Stock? 3 Reasons to Think "Yes"
- GILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo
- Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
- ANI Pharmaceuticals, Inc. (ANIP) Hits Fresh High: Is There Still Room to Run?
- Ani Pharmaceuticals stock hits 52-week high at 90.43 USD
- Axon, DoorDash, Harmony Gold Among Today's Best Stocks To Buy And Watch: Check Out New Names Added To IBD Stock Lists
- ANI Pharmaceuticals stock price target raised to $77 from $65 at Truist Securities
- ANI (ANIP) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
- ANI Pharmaceuticals stock price target raised to $93 from $84 at H.C. Wainwright
- ANI Pharmaceuticals stock price target raised to $93 from $84 at H.C. Wainwright
- Ani Pharmaceuticals stock hits 52-week high at 77.86 USD
- ANI Pharma earnings beat by $0.40, revenue topped estimates
- ANI Pharmaceuticals (ANIP) Q2 Earnings and Revenues Surpass Estimates
- Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Beats Revenue Estimates
- Constellation Software, Under Armour, Muenchener Rueckver set to report Friday
- How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
- Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
- CG Oncology wins Delaware jury trial against ANI Pharmaceuticals
- ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Q2 Release
Range quotidien
91.97
93.72
Range Annuel
52.50
93.72
- Clôture Précédente
- 92.53
- Ouverture
- 93.03
- Bid
- 93.50
- Ask
- 93.80
- Plus Bas
- 91.97
- Plus Haut
- 93.72
- Volume
- 705
- Changement quotidien
- 1.05%
- Changement Mensuel
- 48.13%
- Changement à 6 Mois
- 53.88%
- Changement Annuel
- 48.60%
30 août, samedi